![]() |
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
-Conotoxin MII-Sensitive Subtypes of Nicotinic Acetylcholine Receptors Isolated by Breeding of Null Mutant MiceInstitute for Behavioral Genetics, University of Colorado, Boulder, Colorado (O.S., J.A.D., E.L., M.C., A.C.C., M.J.M., S.R.G.); and Departments of Biology and Psychiatry, University of Utah, Salt Lake City, Utah (J.M.M.)
Subtypes of nicotinic acetylcholine receptors (nAChR) containing
6 subunits comprise 25 to 30% of the presynaptic nAChRs expressed in striatal dopaminergic terminals in rodents and 70% in monkeys. This class of receptors, potentially important in nicotine addiction, binds
-conotoxin MII (
-CtxMII) with high affinity and is heterogeneous, consisting of several subtypes in mice, possibly an important consideration for the design of compounds that selectively activate or antagonize the
6 subclass of nAChRs. Selected-null mutant mice were bred to generate isolated subtypes of
6
2* nAChRs expressed in vivo for assessing pharmacology of
6
2* nAChRs. Binding to striatal membranes and function in synaptosomes from (
4–/–)(
3+/+) and (
4–/–)(
3–/–) mice were measured and compared with wild-type (
4+/+)(
3+/+) mice. Gene deletions (
4 and
3) decreased binding of 125I-
-CtxMII without affecting affinity for
-CtxMII or inhibition of
-CtxMII binding by epibatidine or nicotine. Deletion of the
4 subunit substantially increased EC50 values for both nicotine- and cytisine-stimulated
-CtxMII-sensitive dopamine release from striatal synaptosomes. A further increase in EC50 values was seen upon the additional deletion of the
3 subunit. The data indicate that one
-CtxMII-sensitive nAChR subtype, prevalent on wild-type dopaminergic terminals, has the lowest EC50 for a nicotine-mediated function so far measured in mice. In conclusion, the gene deletion strategy enabled isolation of
6* subtypes, and these nAChR subtypes exhibited differential activation by nicotine and cytisine.
Address correspondence to: Sharon R. Grady, Institute for Behavioral Genetics, University of Colorado, 447UCB, Boulder, CO 80309. E-mail: sharon.grady{at}colorado.edu
This article has been cited by other articles:
![]() |
L. P. Dwoskin, T. E. Wooters, S. P. Sumithran, K. B. Siripurapu, B. M. Joyce, P. R. Lockman, V. K. Manda, J. T. Ayers, Z. Zhang, A. G. Deaciuc, et al. N,N'-Alkane-diyl-bis-3-picoliniums as Nicotinic Receptor Antagonists: Inhibition of Nicotine-Evoked Dopamine Release and Hyperactivity J. Pharmacol. Exp. Ther., August 1, 2008; 326(2): 563 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Kuryatov, J. Onksen, and J. Lindstrom Roles of Accessory Subunits in {alpha}4{beta}2* Nicotinic Receptors Mol. Pharmacol., July 1, 2008; 74(1): 132 - 143. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Drenan, R. Nashmi, P. Imoukhuede, H. Just, S. McKinney, and H. A. Lester Subcellular Trafficking, Pentameric Assembly, and Subunit Stoichiometry of Neuronal Nicotinic Acetylcholine Receptors Containing Fluorescently Labeled {alpha}6 and 3 Subunits Mol. Pharmacol., January 1, 2008; 73(1): 27 - 41. [Abstract] [Full Text] [PDF] |
||||